TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment

<div>Nomogram for predicting the probability of patients with 1-, 3-, and 5-year overall survival. A quantitative method to predict SKCM patients’ probability of 1-, 3-, and 5-year OS. (a) A nomogram for predicting the probability of 1-, 3-, and 5-year OS for SKCM patients. (b) Calibration plots of the nomogram for predicting the probability of OS at 1, 3, and 5 years.</div>

Disease Markers

fig5

Figure 5

Figure 5: TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment 